[go: up one dir, main page]

NO20001717D0 - Serotonin-inneholdende formulering for oral administrering og anvendelse av samme - Google Patents

Serotonin-inneholdende formulering for oral administrering og anvendelse av samme

Info

Publication number
NO20001717D0
NO20001717D0 NO20001717A NO20001717A NO20001717D0 NO 20001717 D0 NO20001717 D0 NO 20001717D0 NO 20001717 A NO20001717 A NO 20001717A NO 20001717 A NO20001717 A NO 20001717A NO 20001717 D0 NO20001717 D0 NO 20001717D0
Authority
NO
Norway
Prior art keywords
serotonin
same
oral administration
containing formulation
formulation
Prior art date
Application number
NO20001717A
Other languages
English (en)
Other versions
NO20001717L (no
Inventor
Robert Posner
Original Assignee
Serotoen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26730230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20001717(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serotoen Inc filed Critical Serotoen Inc
Publication of NO20001717D0 publication Critical patent/NO20001717D0/no
Publication of NO20001717L publication Critical patent/NO20001717L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20001717A 1997-10-08 2000-04-03 Serotonin-inneholdende formulering for oral administrering og anvendelse av samme NO20001717L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6133697P 1997-10-08 1997-10-08
US09/052,135 US6017946A (en) 1997-10-08 1998-03-31 Serotonin containing formulation for oral administration and method of use
PCT/US1998/020481 WO1999017612A1 (en) 1997-10-08 1998-10-06 Serotonin containing formulation for oral administration and method of use

Publications (2)

Publication Number Publication Date
NO20001717D0 true NO20001717D0 (no) 2000-04-03
NO20001717L NO20001717L (no) 2000-04-03

Family

ID=26730230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001717A NO20001717L (no) 1997-10-08 2000-04-03 Serotonin-inneholdende formulering for oral administrering og anvendelse av samme

Country Status (12)

Country Link
US (1) US6017946A (no)
EP (1) EP1021087A4 (no)
JP (1) JP2001518481A (no)
KR (1) KR20010024462A (no)
CN (1) CN1279582A (no)
AU (1) AU9780598A (no)
BR (1) BR9813856A (no)
CA (1) CA2305190A1 (no)
IL (1) IL134958A0 (no)
MX (1) MXPA00003385A (no)
NO (1) NO20001717L (no)
WO (1) WO1999017612A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1320776B1 (it) * 2000-08-07 2003-12-10 Giampiero Valletta Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
JP2003119139A (ja) * 2001-10-12 2003-04-23 Ss Pharmaceut Co Ltd 疲労回復医薬組成物
CN1870992A (zh) 2003-10-03 2006-11-29 维伊林股份有限公司 动物饲料组合物
ATE506948T1 (de) 2003-10-03 2011-05-15 Veijlen N V Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten
RU2361583C2 (ru) * 2003-10-03 2009-07-20 Вейлен Н.В. Применение соединений, способных повышать уровень igf-1 в сыворотке крови, при приготовлении терапевтической композиции для лечения стадий различных заболеваний, ассоциированных со снижением уровня igf-1 в сыворотке людей и животных
JP4147280B2 (ja) * 2003-12-16 2008-09-10 独立行政法人理化学研究所 グルタミン含有エネルギー付加型アミノ酸組成物又はアミノ酸溶液
US8133258B2 (en) * 2006-08-03 2012-03-13 Arthrocare Corporation Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device
EP1925214A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses
WO2019238998A1 (es) * 2018-06-13 2019-12-19 Servicio Andaluz De Salud Uso de antioxidantes para el tratamiento de la depresión en pacientes mayores
EP3856893A1 (en) * 2018-09-27 2021-08-04 Yildiz Teknik Universitesi Composition intended for increasing the velocity of sperms comprising serotonin as active compound
KR20210113716A (ko) 2020-03-09 2021-09-17 (주)아모레퍼시픽 성분 함량이 변화된 녹차 추출물을 포함하는 여성호르몬 조절 이상 질환 또는 증상의 예방, 완화, 개선 또는 치료용 조성물
KR102192573B1 (ko) 2020-08-12 2020-12-18 문종진 생리통 및 피부 트러블의 예방 및 개선용 조성물
IL301656A (en) * 2020-10-12 2023-05-01 Goodcap Pharmaceuticals Ltd Preparations to reduce inflammation to improve or maintain mental or physical health

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883554A (en) * 1970-10-26 1975-05-13 Kyowa Hakko Kogyo Kk Process for preparing 5-hydroxy-tryptophan and its derivatives
DE3104815C2 (de) * 1980-02-13 1983-07-07 Japan Atomic Energy Research Institute, Tokyo Verfahren zur Herstellung eines Verbundstoffs mit Langzeit-Freigabe
US4596807A (en) * 1985-03-26 1986-06-24 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
DE3601472A1 (de) * 1986-01-20 1987-07-23 Fresenius Ag Verwendung von umsetzungsprodukten von reduzierenden zuckern und serotonin oder serotonin-precursoren zur behandlung cerebraler stoerungen
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals

Also Published As

Publication number Publication date
WO1999017612A1 (en) 1999-04-15
CA2305190A1 (en) 1999-04-15
AU9780598A (en) 1999-04-27
EP1021087A4 (en) 2001-08-22
CN1279582A (zh) 2001-01-10
MXPA00003385A (es) 2002-11-20
IL134958A0 (en) 2001-05-20
NO20001717L (no) 2000-04-03
KR20010024462A (ko) 2001-03-26
US6017946A (en) 2000-01-25
BR9813856A (pt) 2000-09-19
EP1021087A1 (en) 2000-07-26
JP2001518481A (ja) 2001-10-16

Similar Documents

Publication Publication Date Title
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
EG24044A (en) pharmaceutical formulation of omeprazole
DE69815833D1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
FI953479A7 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
DE69525148D1 (de) Pharmazeutische formulierung
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
BR9707501A (pt) Composto composição farmacêutica e uso do composto
FI951316L (fi) Peroraalinen formulaatio
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
BR9707808A (pt) Composto composição farmacêutica e uso do composto
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
NO20002526D0 (no) Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav
BR9606066A (pt) Composto e formulação farmacêutica
NO953003D0 (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application